The Therapeutic Potential of microRNAs in Nervous System Damage, Degeneration, and Repair
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
MicroRNAS (miRNAs) have been suggested to play important roles in the central nervous system during development as well as disease. miRNAs appear to be dysregulated in a number of neurodegenerative diseases, developmental disorders, and as a result of stroke. Each miRNA has the ability to regulate hundreds of messenger RNA transcripts, both by causing degradation of the mRNA and by inhibition of protein translation. Recent findings suggest that it may eventually be possible to treat some neurological disorders by restoring or inhibiting miRNAs altered by disease pathology. Both viral delivery and administration of modified oligonucleotides mimicking or inhibiting specific miRNAs have been effective in model systems. Artificial miRNAs have also been generated for the repression of specific transcripts. Alteration of miRNA expression by disease and insult also holds the potential for improved diagnostic tools. Finally, miRNAs have been shown to control cellular proliferation and specification, suggesting that manipulation of miRNAs in cultured cells could result in more convenient generation of pure cell populations for transplantation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways
Grimm, D., Streetz, K. L., Jopling, C. L., Storm, T. A., Pandey, K., Davis, C. R., Marion, P., Salazar, F., & Kay, M. A. (2006) · Nature · doi:10.1038/nature04791 · Cited by 1,677
LNA-mediated microRNA silencing in non-human primates
Elmén, J., Lindow, M., Schütz, S., Lawrence, M., Petri, A., Obad, S., Lindholm, M., Hedtjärn, M., Hansen, H. F., Berger, U., et al. (2008) · Nature · doi:10.1038/nature06783 · Cited by 1,589
Sempere, L. F., Freemantle, S., Pitha-Rowe, I., Moss, E., Dmitrovsky, E., & Ambros, V. (2004) · Genome Biology · doi:10.1186/gb-2004-5-3-r13 · Cited by 1,578
Faghihi, M. A., Modarresi, F., Khalil, A. M., Wood, D. E., Sahagan, B. G., Morgan, T. E., Finch, C. E., St. Laurent III, G., Kenny, P. J., & Wahlestedt, C. (2008) · Nature Medicine · doi:10.1038/nm1784 · Cited by 1,416 · cited 1×
“Altered expression of miRNAs has been observed in Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), Tourette's syndrome, and prion-induced neurodegeneration (Cogswell et al., 2008; Faghihi et al., 2008; Hebert et al., 2008; Packer et al., 2008; Saba et al., 2008; Wang et al., 2008a, 2008b)…”
BackgroundMakeyev, E. V., Zhang, J., Carrasco, M. A., & Maniatis, T. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.07.015 · Cited by 1,395 · cited 2×
“The role of miR-124 has been explored by several groups and has a strong role in regulating neural fate (Conaco et al. 2006, Makeyev et al. 2007).”
BackgroundTransvascular delivery of small interfering RNA to the central nervous system
Kumar, P., Wu, H., McBride, J. L., Jung, K.-E., Hee Kim, M., Davidson, B. L., Kyung Lee, S., Shankar, P., & Manjunath, N. (2007) · Nature · doi:10.1038/nature05901 · Cited by 1,246
A MicroRNA Feedback Circuit in Midbrain Dopamine Neurons
Kim, J., Inoue, K., Ishii, J., Vanti, W. B., Voronov, S. V., Murchison, E., Hannon, G., & Abeliovich, A. (2007) · Science · doi:10.1126/science.1140481 · Cited by 1,187
Hébert, S. S., Horré, K., Nicolaï, L., Papadopoulou, A. S., Mandemakers, W., Silahtaroglu, A. N., Kauppinen, S., Delacourte, A., & De Strooper, B. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710263105 · Cited by 1,183 · cited 3×
“that dysregulation of miRNAs plays a role in both inherited and sporadic forms of AD (Hébert et al., 2008; Wang et al., 2008).”
BackgroundCogswell, J. P., Ward, J., Taylor, I. A., Waters, M., Shi, Y., Cannon, B., Kelnar, K., Kemppainen, J., Brown, D., Chen, C., et al. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14103 · Cited by 943
Sequence Variants in SLITRK1 Are Associated with Tourette's Syndrome
Abelson, J. F., Kwan, K. Y., O'Roak, B. J., Baek, D. Y., Stillman, A. A., Morgan, T. M., Mathews, C. A., Pauls, D. L., Rašin, M.-R., Gunel, M., et al. (2005) · Science · doi:10.1126/science.1116502 · Cited by 940 · cited 2×
“This is strikingly similar to a reported case of a mutation observed in Tourette’s syndrome, where the 30 UTR of the SLITRK1 gene resulting in lack of miR-189 being able to repress SLITRK1 (Abelson et al. 2005).”
ResultRole of microRNAs in vascular diseases, inflammation, and angiogenesis
Urbich, C., Kuehbacher, A., & Dimmeler, S. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn156 · Cited by 880 · cited 1×
“Other disease-related processes, such as inflammation, also alter miRNA expression and therapy might be mediated by manipulation of these miRNAs as well (see Urbich et al. 2008; Sheedy and O’Neill 2008 for reviews).”
Impaired Proteasome Function in Alzheimer's Disease
Keller, J. N., Hanni, K. B., & Markesbery, W. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750436.x · Cited by 848 · cited 2×
“Together with age-related impairment of proteasomal degradation (Keller et al., 2000; Hol et al., 2005), increased production of APP, tau and synuclein may result in the accumulation of these pathogenic proteins within vulnerable neuronal populations.”
Microarray analysis of microRNA expression in the developing mammalian brain
Miska, E. A., Alvarez-Saavedra, E., Townsend, M., Yoshii, A., Šestan, N., Rakic, P., Constantine-Paton, M., & Horvitz, H. R. (2004) · Genome Biology · doi:10.1186/gb-2004-5-9-r68 · Cited by 803 · cited 1×
“The developing and mature central nervous system (CNS) expresses one of the richest diversities of miRNAs of any tissue (Krichevsky et al. 2006; Miska et al. 2004; Sempere et al. 2004; Smirnova et al. 2005; Baek et al. 2008; Kapsimali et al. 2007).”
MicroRNA-Mediated Feedback and Feedforward Loops Are Recurrent Network Motifs in Mammals
Tsang, J., Zhu, J., & van Oudenaarden, A. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.018 · Cited by 740 · cited 1×
“This is similar to a feedback loop observed between miR-133b and Pitx3 (Kim et al. 2007) and may represent a general theme in miRNA regulation that should be taken into consideration when planning miRNA-based therapies ( Tsang et al. 2007 ).”
BackgroundReciprocal actions of REST and a microRNA promote neuronal identity
Conaco, C., Otto, S., Han, J.-J., & Mandel, G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511041103 · Cited by 736 · cited 5×
“The role of miR-124 has been explored by several groups and has a strong role in regulating neural fate (Conaco et al. 2006, Makeyev et al. 2007).”
InfluentialRegulation of miRNA expression during neural cell specification
Smirnova, L., Gräfe, A., Seiler, A., Schumacher, S., Nitsch, R., & Wulczyn, F. G. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03978.x · Cited by 707 · cited 1×
“The developing and mature central nervous system (CNS) expresses one of the richest diversities of miRNAs of any tissue (Krichevsky et al. 2006; Miska et al. 2004; Sempere et al. 2004; Smirnova et al. 2005; Baek et al. 2008; Kapsimali et al. 2007).”
Specific microRNAs modulate embryonic stem cell-derived neurogenesis.
Krichevsky, A. M., Sonntag, K.-C., Isacson, O., & Kosik, K. S. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0441 · Cited by 692
Harper, S. Q., Staber, P. D., He, X., Eliason, S. L., Martins, I. H., Mao, Q., Yang, L., Kotin, R. M., Paulson, H. L., & Davidson, B. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501507102 · Cited by 682
Packer, A. N., Xing, Y., Harper, S. Q., Jones, L., & Davidson, B. L. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2390-08.2008 · Cited by 679 · cited 6×
“Screening for miRNAs in HD brain tissue samples has demonstrated that expression of several miRNAs change with disease progression in both mouse models of HD and in human patients (Johnson et al. 2008; Packer et al. 2008 ).”
BackgroundInfluentialPerkins, D. O., Jeffries, C. D., Jarskog, L. F., Thomson, J. M., Woods, K., Newman, M. A., Parker, J. S., Jin, J., & Hammond, S. M. (2007) · Genome Biology · doi:10.1186/gb-2007-8-2-r27 · Cited by 574 · cited 1×
“Additionally, depression and mental health disorders such as schizophrenia also appear to involve changes in miRNA expression (Beveridge et al. 2008; Burmistrova et al. 2007; Perkins et al. 2007).”
Lukiw, W. J., Zhao, Y., & Cui, J. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805371200 · Cited by 441
Kapsimali, M., Kloosterman, W. P., de Bruijn, E., Rosa, F., Plasterk, R. H., & Wilson, S. W. (2007) · Genome Biology · doi:10.1186/gb-2007-8-8-r173 · Cited by 376 · cited 2×
“The developing and mature central nervous system (CNS) expresses one of the richest diversities of miRNAs of any tissue (Krichevsky et al. 2006; Miska et al. 2004; Sempere et al. 2004; Smirnova et al. 2005; Baek et al. 2008; Kapsimali et al. 2007).”
De Pietri Tonelli, D., Pulvers, J. N., Haffner, C., Murchison, E. P., Hannon, G. J., & Huttner, W. B. (2008) · Development · doi:10.1242/dev.025080 · Cited by 343
Mellios, N., Huang, H.-S., Grigorenko, A., Rogaev, E., & Akbarian, S. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn201 · Cited by 274 · cited 1×
“Additionally, miR-30a-5p has been shown to inhibit BDNF in the prefrontal cortex (Mellios et al. 2008).”
BackgroundA miRNA signature of prion induced neurodegeneration.
Saba, R., Goodman, C. D., Huzarewich, R. L. C. H., Robertson, C., & Booth, S. A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003652 · Cited by 251 · cited 2×
“Altered expression of miRNAs has been observed in Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), Tourette's syndrome, and prion-induced neurodegeneration (Cogswell et al., 2008; Faghihi et al., 2008; Hebert et al., 2008; Packer et al., 2008; Saba et al., 2008; Wang et al., 2008a, 2008b)…”
Adding fuel to fire: microRNAs as a new class of mediators of inflammation
Sheedy, F. J., & O'Neill, L. A. J. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.100289 · Cited by 246 · cited 1×
“Other disease-related processes, such as inflammation, also alter miRNA expression and therapy might be mediated by manipulation of these miRNAs as well (see Urbich et al. 2008; Sheedy and O’Neill 2008 for reviews).”
Cataldo, A. M., Petanceska, S., Peterhoff, C. M., Terio, N. B., Epstein, C. J., Villar, A., Carlson, E. J., Staufenbiel, M., & Nixon, R. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-17-06788.2003 · Cited by 241 · cited 2×
“Data from studies of trisomy 16 mice, a model of Down syndrome, suggest that increased APP expression is sufficient to cause neuropathological changes similar to those of AD (Cataldo et al., 2003; Salehi et al., 2006).”
Cited by
An antagomir to microRNA Let7f promotes neuroprotection in an ischemic stroke model
Selvamani, A., Sathyan, P., Miranda, R. C., & Sohrabji, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032662 · Cited by 217
“Manipulating endogenous miRNA levels by viral vectors or modified oligoneucleotides to mimic or inhibit miRNA are effective in vivo and in-vitro [74].”
BackgroundMiR-137: an important player in neural development and neoplastic transformation
Mahmoudi, E., & Cairns, M. J. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.150 · Cited by 198
Zhao, H., Wang, J., Gao, L., Wang, R., Liu, X., Gao, Z., Tao, Z., Xu, C., Song, J., Ji, X., et al. (2013) · Stroke · doi:10.1161/strokeaha.111.000504 · Cited by 188
MicroRNA Dysregulation in the Spinal Cord following Traumatic Injury
Yunta, M., Nieto-Díaz, M., Esteban, F. J., Caballero-López, M., Navarro-Ruíz, R., Reigada, D., Pita-Thomas, D. W., Águila, Á. D., Muñoz-Galdeano, T., & Maza, R. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034534 · Cited by 122
Yin, H., Song, S., & Pan, X. (2017) · Journal of Inflammation · doi:10.1186/s12950-017-0162-7 · Cited by 53
Metadata
- Authors
- Hutchison, E. R., Okun, E., & Mattson, M. P.
- Venue
- NeuroMolecular Medicine
- Published
- 2009-09
- Volume
- 11
- Issue
- 3
- Pages
- 153-161
- ISSN
- 1535-1084 (ISSN-L)
- 1559-1174
- OpenAlex
- W1986680046
- Cited by
- 51
- References
- 27
- FWCI
- 1.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.